==== Front Ann Saudi MedAnn Saudi MedAnnals of Saudi Medicine0256-49470975-4466King Faisal Specialist Hospital and Research Centre 2215663710.5144/0256-4947.2012.32asm-1-32Original ArticleEosinophilic pneumonia: experience at two tertiary care referral hospitals in Saudi Arabia Al-Jahdali Hamdan aWaness Abdelkarim bAl-Jawder Suhaila cBaharoon Salim A. aAl-Muhsen Saleh dAl-Mobeireek Abdullah cSalama Reda aHalwani Rabih d a Department of Medicine, King Saud University for Health Sciences b Medicine Institute, Sheikh Khalifa Medical City Research Center, Abu Dhabi United Arab Emirates c Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia d Asthma Research Chair and Prince Naif Center for Immunology Research, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Dr. Hamdan Al-Jahdali, Department of Medicine, Pulmonary Division, Head of Pulmonary Division, King Saud University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia, T: +96612520088 ext 17597, 17530, M:+966505224271, Jahdali@yahoo.comJan-Feb 2012 32 1 32 36 01 1 2011 Copyright © 2012, Annals of Saudi Medicine2012This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.BACKGROUND AND OBJECTIVE Eosinophilic lung diseases are a diverse group of disorders characterized by pulmonary opacities associated with tissue or peripheral eosinophilia. DESIGN AND SETTING A retrospective study conducted at two tertiary care hospitals from January 1999 to December 2009. METHODS All cases with the diagnosis of pulmonary eosinophilia were reviewed over a period of 10 years. Data on demographic, clinical, and radiologic characteristics were collected. RESULTS Thirty-five patients with a mean age of 33.9 (16.2) years, of which 20 (57.1%) were male and meeting the criteria of eosinophilic lung disease were identified. Cough and dyspnea were the most frequent symptoms at presentation in 29 (82.9%) and 27 (77.1%) patients, respectively. Reticulonodular and airspace patterns were the most common radiographic findings in 17 (48.6%) and 15 (42.9%) patients, respectively. Peripheral eosinophilia was present in 33 (94.3%) patients. Twenty-four patients (68.6%) were labeled as having idiopathic pulmonary infiltrate with eosinophilia. Complete remission was achieved in 13 (54.2%) of 24 patients, while 10 (41.7%) patients relapsed within a few months of discontinuation of therapy. Specific therapy for a specific disease was administered in 8 patients: 2 patients for pulmonary tuberculosis, 2 for Churg–Strauss syndrome, 1 for lymphoma, 1 for schistosomiasis, 1 for acute eosinophilic pneumonia, and 1 for Wegener granuloma; 3 patients were treated as allergic bronchopulmonary aspergillosis. CONCLUSIONS Pulmonary eosinophilia remains rare but challenging, and it can have the same diverse clinical and radiographic presentations seen with other common pulmonary conditions. Clinicians should be alert to these syndromes and must think of them in any lung disease differential diagnoses. ==== Body Eosinophilic lung diseases are a heterogeneous group of disorders characterized by abnormal accumulation of eosinophils in the distal airways, air spaces, and the interstitial compartment of the lung, with or without peripheral blood eosinophilia.1–3 The first detailed description of chronic eosinophilic pneumonia (CEP) was provided by Carrington et al, in 1969.4 The specrtum of this respiratory syndrome includes eosinophilic lung disease of known causes, which include allergic bronchopulmonary aspergillosis (ABPA), bronchocentric granulomatosis, parasitic infections, drug reactions, and eosinophilic vasculitis (allergic angiitis, Churg–Strauss syndrome), and eosinophilic lung disease of unknown causes, which include simple pulmonary eosinophilia, also known as Loeffler syndrome, acute eosinophilic pneumonia (AEP), CEP, and idiopathic hypereosinophilic syndrome. 1,3,5–10 Infectious causes of pulmonary eosinophilia include parasitic infections, particularly ascariasis and Mycobacterium tuberculosis.11–13 Diagnosing eosinophilic lung disease is challenging because of the overlap of the clinical and radiological presentation with those of other forms of diffuse lung diseases. The clinical presentation can range from chronic to a subacute form to even acute respiratory failure. Radiological presentations range from pulmonary infiltrates, which might be minimal, to migratory ones, or diffuse and bilateral presentations.14–16 Accurate identification of the underlying cause, when possible, is important because it can influence treatment. Corticosteroids remain the cornerstone in treating eosinophilic lung diseases.14 Despite the high response rate, there is a chance of relapse and recurrence of the disease. The incidence and prevalence of eosinophilic pneumonia in Saudi Arabia is not known. Medical knowledge regarding eosinophilic lung diseases has been acquired mostly from case series and case reports. In this study, we have performed a retrospective evaluation of our experience with eosinophilic lung diseases in the last 10 years. METHODS We used medical records with the coding system of the diseases and the pathology database to retrospectively review all cases with a diagnosis of pulmonary esoinophilia over a period of 10 years, from January 1999 to December 2009, at the King Abdualziz Medical City (KAMC) and King Faisal Specialist Hospital and Research Center, both in Riyadh, Saudi Arabia. This study was approved by the KAMC ethics committee. We included all cases with a diagnosis of eosinophilic lung disease that were based on two or more of the following criteria: an increased number of eosinophils in peripheral blood, eosinophilic infiltration of the lung biopsy, or more than 10% eosinophilia in bronchoalveolar lavage (BAL) fluid. We excluded all cases in which the secondary etiology was known, such as secondary to drug reaction or parasitic infection, or diagnosed clinically without tissue confirmation. Data were collected on the demographic characteristics, symptoms, physical findings at presentation, treatment administered and response to therapy, and cause of disease after therapy. All pathology reports were reviewed; chest x-ray and computed tomography (CT) reports were also reviewed, and if the reports were not avaliable, then films were reviewed by a radiologist. All laboratory data pertinent to the diagnosis of pulmonary eosinophila were also collected. RESULTS We identified 35 patients from 1999 to 2009 fulfilling the criteria of eosinophilic lung disease, comprising 20 (57.1%) males and 15 (42.9%) females, with a mean age of 33.9 (16.2) years. Bronchial asthma was the most common comorbidity diagnosed in 18 patients (51.4%). Cough and dyspnea were the most frequent symptoms at presentation in 29 (82.9%) and 27 (77.1%) patients, respectively. Other symptoms included fever in 11 patients (31.4%), weight loss in 11 patients (31.4%), and arthralgia in 7 patients (20%) (Table 1). Chest examination was normal in 12 (34.3%) patients, while crackles and wheezing were present in 23 (65.7%) patients. Physical findings were bilateral in 21 (60%) patients and unilateral in only 2 (5.7%) patients. Radiological findings at presentation are summarized in Table 2. A reticulonodular pattern was the most frequent pattern encountered in plain chest x-ray, with 17 (48.6%) patients. This was closely followed by airspace pattern, with 15 (42.9%) patients. Pleural involvement was present in 11 (31.4%) patients. Chest CT was carried out for all patients. Mediastinal lymphadenopathy was seen in 9 (25.7%) patients, even though reported as nonsignificant. Reticulonodular and airspace disease patterns were the most commonly encountered abnormalities, with 17 (48.6%) and 16 (45.7%) cases, respectively. Almost all radiologic abnormalities were bilateral in CT of the chest, with 30 (85.7%) patients. Peripheral eosinophilia (more than 10% in the peripheral smear) was present in 33 (94.3%) patients; the mean (SD) eosinophilic count was 26.8 (12.3). Fiberoptic bronchoscopy was performed on 32 (91.4%) patients, and transbronchial biopsy was performed on 25 (71.4%) of them. Transthoracic biopsy and thoracoscopic biopsy were performed on 4 (11.4%) and 6 (17.1%) patients, respectively (Table 3). BAL was performed on 18 patients, and the sputum cell count and differential count were obtained from all of them; eosinophilia (>10%) was present in 16 of 18 (88.9%) patients. Twenty-four (68.6%) patients were labeled as idiopathic pulmonary infiltrate with eosinophilia. One case was diagnosed as schistosomiasis based on the biopsy finding showing schistosomiasis ova in the lung biopsy and subsequent high-serum titer of schistosomiasis; the patient improved after treatment with antischistosomiasis therapy. Other diagnoses are shown in Table 4. Complete remission with no further relapse was achieved in 13 (54.2%) of 24 patients labeled as idiopathic eosinophilic pneumonia after treatment for 6 months to 1 year, and no relapse up to 1 year from stopping corticosteroids, while 10 (41.7%) patients relapsed within a few months of discontinuation of therapy and required reinstitution of steroid and 1 patient was lost to follow-up. Specific therapy for a specific disease was administered in 8 patients: in 2 patients for pulmonary tuberculosis, 2 for Churg–Strauss syndrome, 1 for lymphoma, 1 for schistosomiasis, 1 for AEP, and 1 for Wegener granuloma. Three patients were treated for ABPA with variable doses of corticosteroids for a short period ranging from 2 to 4 weeks. DISCUSSION Pulmonary eosinophilic syndromes are rare and are generally placed under two broad categories: (1) extrinsic eosiniphilic sydromes [such as parasitic or fungal causes, AEP, Loeffler, or DRESS (drug rash with eosinophilia and systemic symptoms) syndromes] and (2) intrinsic eosinophilic syndromes with mostly unknown pathogenesis as in CEP, eosinophilic granuloma, or Churg–Strauss syndrome.17 In our series, less than one-third of patients had an identifiable extrinsic etiology while the remainder were idiopathic in nature. We are presuming that the latter had intrinsic causes, but definitive diagnoses were not established. We also tended to classify most as idiopathic chronic eosinophilic pneumonia (ICEP) or Carrington disease for two main reasons known with this condition: its close relationship with asthma and its exceptional response to corticosteroid therpy.17,18 In addition, no other etiologies were identified during the follow-up period. Bronchial asthma has been reported in 30% to 50% of patients with chronic eosinophilic pneumonia.10 In Saudi Arabia, the prevalence of asthma has been on the rise recently.19 Not all patients with asthma have clinically significant symptoms and are diagnosed or treated in a timely fashion. In our series, asthma was diagnosed in more than half of them. Furthermore, the positive response to glucocorticoid treatment was achieved in more than 95% of our patients with idiopathic pulmonary eosinophilia. Therefore, these findings strengthen the likelihood of ICEP as the main diagnosis in our patients, as postulated earlier. These findings are also interesting from another angle. The rate of identifiable extrinsic etiologies in our series was relatively low. We diagnosed only two patients (5.7%) with tuberculosis causing pulmonary eosinophilia. This has been reported previously.20 This is surprinsingly low in a country where tuberculosis is prevalent, and probaly even underdiagnosed.21 Furthermore, one single case (2.7%) of AEP was identified. Again, this finding is extremely low, knowing that the prevalence of cigarette smoking is high in the Saudi population,22 and any change in the smoking habit is associated with the development of AEP.23 It is possible that such less-severe and transient cases were presented to primary care centers and general hospitals, and that only the more severe and symptomatic cases came to our study hospitals (which are tertiary care hospitals). One case of peripheral eosinophilia Wegener granulomatosis was reported in our series; however, this has also been reported previously.24,25 Pulmonary eosinophilia was reported to have a gender predilection. Some studies report a female preponderance, while in our series the opposite was observed (57%). Symptoms reported by patients in our series were diverse and well known for their association with pulmonary eosinophilic syndromes. Cough, dyspnea, fever, followed by other presentations such as wheezing are documented and recognized.26 Bronchoscopy with BAL demonstrated a high eosinophil level in the eosinophilic lung. This finding, associated with the clinical presentation, peipheral eosinophilia, and the radiographic evaluation is helpful in the diagnosis. Extremely rare cases of ICEP without eosinophils in the bronchial lavage can occur occasionally.27 In keeping with previous studies, radiographic presentations in our series were varied. In the eosinophilic lung, all forms of parenchymal opacities can be observed in both standard radiography and CT, the latter being better in demonstrating the ground-glass appearance.28,29 Mediastinal adenopathies and pleural effusions are also common findings.30 Most of our patients responded well to the classic therapy with corticosteroids. This treatment can be administered in its intravenous, oral, or inhaled forms, with a variable treatment duration.18,31 Our patients also did very well with glucocorticoid treatment. This treatment reversed not only the respiratory symptoms of this disease but also possibly the extrapulmonary eosinophilic manifestations. Padi and colleagues reported a reversal of left bundle branch block in a young female with severe eosinophilia, fever, wheezing, and abnormal CT chest findings after treatment with steroids.32 In conclusion, pulmonary eosinophilic syndromes remain rare, but challenging. They can have diverse clinical symptomatology and a wealth of radiographic presentations seen with other much-common pulmonary conditions. Clinicians should be alert to these syndromes and must think of them in the differential diagnoses of any lung disease. Eosinophilia can provide an important clue toward clinching the diagnosis. Bronchoscopy with BAL and, occasionally, lung biopsy remain the gold standard for establishing the diagnosis. Certainly more prospective studies are needed to better elucidate the scope of these syndromes in areas where trigger factors (such as asthma, cigarette abuse, medication use) are on the rise. Table 1 Patient characteristics and presenting symptoms. Characteristics No. (35) % Gender  Male 20 57.1  Female 15 42.9 Symptoms  Cough 29 82.9  Dyspnea 27 77.1  Fever 11 31.4  Weight loss 11 31.4  Wheezing 10 28.6  Arthritis/arthlalgia 7 20.0  Night sweat 5 14.3  Chest pain 5 14.3  Sinusitis 4 11.4  Hemoptysis 4 11.4  Skin rash 3 08.6  Others 10 28.6 Table 2 Radiologic features. Characteristics Number % Radiology chest x-ray  Reticulonodular 17 48.6  Airspace 15 42.9  Cavity/mass 4 11.4  Pleural 11 31.4  Effusion 9 25.7  Thickening 2 5.7 Chest CT scan findings  Lymphadenopathy 9 25.7  Mediastinal 5 14.3  Hilar 8 22.9 Parenchyma radiological pattern  Airspace 16 45.7  Interstitial (reticulonodular) 17 48.6  Ground-glass appearance 9 25.7  Other (mass/cavity) 2 5.7  Pleural 6 17.1  Effusion 10 28.6  Thickening 2 5.7 Location of abnormalities  Bilateral 30 85.7  Unilateral 5 14.3 Table 3 Diagnostic procedures. Characteristics Number % Procedure  Bronchoscopy 32 91.4  Transbronchial biopsy (TBBx) 25 71.4  Bronchioalveolar lavage (BAL) 18 51.4  Transthoracic biopsy 4 11.4  Thoracoscopic biopsy 6 17.1  Others 8 22.9 Pathology result (for 31 patients)  Eosinophilia tissue infiltration 29 93.5  Inflammation and granuloma 2 6.5 BAL differential result (for 18 patients)  Eosinophilia (>10%) 16 88.9  Macrophages 1 5.5  Reactive bronchial cell 1 5.5  Reactive bronchial cell and macrophages 2 8.7  Reactive bronchial cell and eosinophilia 1 5.5  Normal 2 8.7 Table 4 Final diagnosis. Characteristics Number % Idiopathic pulmonary eosinophiliaa 24 68.6 ABPA 3 8.6 Churg–Strauss syndrome 2 5.7 Schistomiasis 1 2.9 Acute eosinophilic pneumonia 1 2.9 Hodgkin lymphoma 1 2.9 Pulmonary TB 2 5.7 Wegner granuloma 1 2.9 a Pulmonary infiltrate with eosinophilia with no specific underlying etiology. ==== Refs REFERENCES 1 Alam M Burki NK Chronic eosinophilic pneumonia: A review South Med J 2007 100 49 53 17269525 2 Allen JN Davis WB What is eosinophilic pneumonia? Arch Intern Med 1992 152 1765 6 1520042 3 Allen JN Magro CM King MA The eosinophilic pneumonias Semin Respir Crit Care Med 2002 23 127 34 16088605 4 Carrington CB Addington WW Goff AM Madoff IM Marks A Schwaber JR Chronic eosinophilic pneumonia N Engl J Med 1969 280 787 98 5773637 5 Allen JN Pacht ER Gadek JE Davis WB Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure N Engl J Med 1989 321 569 74 2761601 6 Bain GA Flower CD Pulmonary eosinophilia Eur J Radiol 1996 23 3 8 8872069 7 Gonzalez EB Hayes D Weedn VW Chronic eosinophilic pneumonia (Carrington’s) with increased serum IgE levels. A distinct subset? Arch Intern Med 1988 148 2622 4 3058073 8 Guillevin L Cohen P Gayraud M Lhote F Jarrousse B Casassus P Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients Medicine (Baltimore) 1999 78 26 37 9990352 9 Solomon J Schwarz M Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia Semin Respir Crit Care Med 2006 27 192 7 16612770 10 Marchand E Cordier JF Idiopathic chronic eosinophilic pneumonia Semin Respir Crit Care Med 2006 27 134 41 16612764 11 Sarinas PS Chitkara RK Ascariasis and hookworm Semin Respir Infect 1997 12 130 7 9195678 12 Inoue K Inoue Y Arai T Nawa Y Kashiwa Y Yamamoto S Chronic eosinophilic pneumonia due to visceral larva migrans Intern Med 2002 41 478 82 12135183 13 Kuzucu A Parasitic diseases of the respiratory tract Curr Opin Pulm Med 2006 12 212 21 16582677 14 Wechsler ME Pulmonary eosinophilic syndromes Immunol Allergy Clin North Am 2007 27 477 92 17868860 15 Steinfeld S Golstein M De Vuyst P Chronic eosinophilic pneumonia (CEP) as a presenting feature of Churg-Strauss syndrome (CSS) Eur Respir J 1994 7 2098 7875290 16 Hayakawa H Sato A Toyoshima M Imokawa S Taniguchi M A clinical study of idiopathic eosinophilic pneumonia Chest 1994 105 1462 6 8181338 17 Marchand E Etienne-Mastroianni B Chanez P Lauque D Leclerc P Cordier JF Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J 2003 22 8 13 12882444 18 Minakuchi M Niimi A Matsumoto H Amitani R Mishima M Chronic eosinophilic pneumonia: treatment with inhaled corticosteroids Respiration 2003 70 362 6 14512670 19 Al Frayh AR Shakoor Z Gad El Rab MO Hasnain SM Increased prevalence of asthma in Saudi Arabia Ann Allergy Asthma Immunol 2001 86 292 6 11289327 20 Vijayan VK Reetha AM Jawahar MS Sankaran K Prabhakar R Pulmonary eosinophilia in pulmonary tuberculosis Chest 1992 101 1708 9 1600796 21 Bukhary ZA Alrajhi AA Tuberculosis treatment outcome in a tertiary care setting Ann Saudi Med 2007 27 171 4 17568168 22 Bassiony MM Smoking in Saudi Arabia Saudi Med J 2009 30 876 81 19617999 23 Uchiyama H Suda T Nakamura Y Shirai M Gemma H Shirai T Alterations in smoking habits are associated with acute eosinophilic pneumonia Chest 2008 133 1174 80 18263675 24 Potter MB Fincher RK Finger DR Eosinophilia in Wegener’s granulomatosis Chest 1999 116 1480 3 10559120 25 Krupsky M Landau Z Lifschitz-Mercer B Resnitzky P Wegener’s granulomatosis with peripheral eosinophilia. Atypical variant of a classic disease Chest 1993 104 1290 2 8404215 26 Katz U Shoenfeld Y Pulmonary eosinophilia Clin Rev Allergy Immunol 2008 34 367 71 18197481 27 Marcq M de Muret A Letourmy JM Anthonioz P Dupont P Diot P Carrington’s disease without eosinophils in the bronchial lavage Rev Mal Respir 2007 24 896 9 17925674 28 Martins RR Marchiori E Viana SL Grillo LS Júnior Capelozzi VL Valença LM Chronic eosinophilic pneumonia secondary to long-term use of nitrofurantoin: high-resolution computed tomography findings J Bras Pneumol 2008 34 181 4 18392467 29 Marchand E Reynaud-Gaubert M Lauque D Durieu J Tonnel AB Cordier JF Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d’Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM”O”P) Medicine (Baltimore) 1998 77 299 312 9772920 30 Tzilas V Bastas A Koti A Papandrinopoulou D Tsoukalas G A 77 year old male with peripheral eosinophilia, pulmonary infiltrates and a small pleural effusion Eur Rev Med Pharmacol Sci 2009 13 227 32 19673174 31 Naughton M Fahy J FitzGerald MX Chronic eosinophilic pneumonia. A long-term follow-up of 12 patients Chest 1993 103 162 5 8031327 32 Padi A Silverman B Schneider A Twenty-one year old woman with severe eosinophilia and left bundle branch block Allergy Asthma Proc 2009 30 558 62 19843409